re: Ann: PGL: Progen Subsidiary Secures New M... Welcome to PharmaSynth
At PharmaSynth, Science, Innovation and Experience come together to provide a trouble free passage from selecting a CMO to finished product. This site will allow you to obtain more information on the PharmaSynth service offer as well as some tips on how to select a CMO and prepare for the tech transfer experience.
Our services are bound by a commitment to finding the best way to providing a solution to client needs and finding innovative ways of solving problems. We utilise our extensive experience in development of cGMP manufacturing processes and subsequent production. PharmaSynth takes pride in providing a quality manufacturing service to an international standard.
PharmaSynth provides the following pharmaceutical services:
?Process development
?Scale up and technology transfer
?cGMP manufacture
?Biopharmaceutical manufacture from bacterial or yeast fermentation
?Synthetic small molecule manufacture
?Pilot scale to commercial
?Human and veterinary manufacture
?Stability testing
?Analytical services
?Regulatory support
?TGA / APVMA / OGTR inspected and approved
Kens
- Forums
- ASX - By Stock
- Ann: Progen Subsidiary Secures New Manufacturing
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)